Usefulness of scoring right ventricular function for assessment of prognostic factors in patients with chronic thromboembolic pulmonary hypertension. 2018

Yoshihiro Kamimura, and Naoki Okumura, and Shiro Adachi, and Shigetake Shimokata, and Fumitaka Tajima, and Yoshihisa Nakano, and Akihiro Hirashiki, and Toyoaki Murohara, and Takahisa Kondo
Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Shouwa-ku, Nagoya, 466-8550, Japan.

Right ventricular (RV) function is associated with prognosis in chronic thromboembolic pulmonary hypertension (CTEPH). This study aimed to establish an RV dysfunction score using RV echocardiographic parameters to clarify the clinical characteristics in patients with CTEPH and to compare RV dysfunction score with parameters such as World Health Organization (WHO) functional class, hemodynamics, exercise capacity, and plasma BNP level. We enrolled 35 inpatients with CTEPH (mean age, 62 ± 15 years, 15 males). We constructed 'an RV dysfunction score' calculated as the summation of each point awarded for the presence of four parameters: tricuspid annular plane systolic excursion (TAPSE) < 16 mm, 1 point; tissue Doppler-derived tricuspid lateral annular systolic velocity (S') < 10 cm/s, 1 point; right ventricular fractional area change (RVFAC) < 35%, 1 point; and right ventricular myocardial performance index (RV-MPI) > 0.4, 1 point. TAPSE, S', RVFAC, and RV-MPI was 18.7 ± 4.8 mm, 11.9 ± 3.1 cm/s, 33.5 ± 13.9%, and 0.39 ± 0.2, respectively. The RV dysfunction score was associated with symptom [WHO functional class (p = 0.026)], hemodynamics [mean PAP (p = 0.01), cardiac index (p = 0.009), pulmonary vascular resistance (p = 0.001), and SvO2 (p = 0.039)], exercise capacity [6-min walk distance (p = 0.046), peakVO2 (p = 0.016), and VE/VCO2 slope (p = 0.031)], and plasma BNP level (p = 0.005). This RV dysfunction score using the four RV echocardiographic parameters could be a simple and useful scoring system to evaluate prognostic factors in patients with CTEPH.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D011655 Pulmonary Embolism Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS. Pulmonary Thromboembolism,Thromboembolism, Pulmonary,Embolism, Pulmonary,Embolisms, Pulmonary,Pulmonary Embolisms,Pulmonary Thromboembolisms,Thromboembolisms, Pulmonary
D011669 Pulmonary Wedge Pressure The blood pressure as recorded after wedging a CATHETER in a small PULMONARY ARTERY; believed to reflect the PRESSURE in the pulmonary CAPILLARIES. Pulmonary Artery Wedge Pressure,Pulmonary Capillary Wedge Pressure,Pulmonary Venous Wedge Pressure,Wedge Pressure,Pressure, Pulmonary Wedge,Pressures, Pulmonary Wedge,Pulmonary Wedge Pressures,Wedge Pressure, Pulmonary,Wedge Pressures, Pulmonary,Pressure, Wedge,Pressures, Wedge,Wedge Pressures
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females

Related Publications

Yoshihiro Kamimura, and Naoki Okumura, and Shiro Adachi, and Shigetake Shimokata, and Fumitaka Tajima, and Yoshihisa Nakano, and Akihiro Hirashiki, and Toyoaki Murohara, and Takahisa Kondo
December 2022, Journal of clinical medicine,
Yoshihiro Kamimura, and Naoki Okumura, and Shiro Adachi, and Shigetake Shimokata, and Fumitaka Tajima, and Yoshihisa Nakano, and Akihiro Hirashiki, and Toyoaki Murohara, and Takahisa Kondo
November 2015, Journal of visualized experiments : JoVE,
Yoshihiro Kamimura, and Naoki Okumura, and Shiro Adachi, and Shigetake Shimokata, and Fumitaka Tajima, and Yoshihisa Nakano, and Akihiro Hirashiki, and Toyoaki Murohara, and Takahisa Kondo
January 2015, The American journal of cardiology,
Yoshihiro Kamimura, and Naoki Okumura, and Shiro Adachi, and Shigetake Shimokata, and Fumitaka Tajima, and Yoshihisa Nakano, and Akihiro Hirashiki, and Toyoaki Murohara, and Takahisa Kondo
August 2023, Cardiology in review,
Yoshihiro Kamimura, and Naoki Okumura, and Shiro Adachi, and Shigetake Shimokata, and Fumitaka Tajima, and Yoshihisa Nakano, and Akihiro Hirashiki, and Toyoaki Murohara, and Takahisa Kondo
October 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Yoshihiro Kamimura, and Naoki Okumura, and Shiro Adachi, and Shigetake Shimokata, and Fumitaka Tajima, and Yoshihisa Nakano, and Akihiro Hirashiki, and Toyoaki Murohara, and Takahisa Kondo
May 2022, Circulation journal : official journal of the Japanese Circulation Society,
Yoshihiro Kamimura, and Naoki Okumura, and Shiro Adachi, and Shigetake Shimokata, and Fumitaka Tajima, and Yoshihisa Nakano, and Akihiro Hirashiki, and Toyoaki Murohara, and Takahisa Kondo
February 2023, Journal of the American Heart Association,
Yoshihiro Kamimura, and Naoki Okumura, and Shiro Adachi, and Shigetake Shimokata, and Fumitaka Tajima, and Yoshihisa Nakano, and Akihiro Hirashiki, and Toyoaki Murohara, and Takahisa Kondo
June 2012, Minerva cardioangiologica,
Yoshihiro Kamimura, and Naoki Okumura, and Shiro Adachi, and Shigetake Shimokata, and Fumitaka Tajima, and Yoshihisa Nakano, and Akihiro Hirashiki, and Toyoaki Murohara, and Takahisa Kondo
May 2019, American journal of respiratory and critical care medicine,
Yoshihiro Kamimura, and Naoki Okumura, and Shiro Adachi, and Shigetake Shimokata, and Fumitaka Tajima, and Yoshihisa Nakano, and Akihiro Hirashiki, and Toyoaki Murohara, and Takahisa Kondo
November 2019, Echocardiography (Mount Kisco, N.Y.),
Copied contents to your clipboard!